Summary:
The dental sector is a broad and fast‑growing segment of the medical device industry, covering products from basic instruments to advanced implant systems, digital dentistry solutions, materials, and 3D‑printed restorations across all MDR risk classes. Under the European MDR 2017/745, manufacturers face increasing regulatory complexity due to borderline classifications, diverse use cases, and high expectations for safety and performance.
The 2025 updates to ISO 10993‑1 and ISO 7405 significantly strengthen biological evaluation requirements, particularly for dental materials with long‑term or repeated patient contact. Biological evaluation is now clearly defined as a continuous lifecycle process, requiring reassessment of device categorisation, biological risks, and exposure conditions, even for legacy devices.
Key Sections Covered:
This document is essential because it provides clear, up‑to‑date guidance on how to meet the increasingly complex MDR and ISO requirements for dental medical devices. It helps manufacturers ensure their biological evaluation, risk management, and validation activities remain aligned with the 2025 updates to ISO 10993‑1 and ISO 7405. By addressing dental‑specific challenges such as materials, implants, reprocessing, and digital technologies, it supports consistent regulatory compliance while reducing the risk of delays, non‑conformities, and unnecessary testing.
Click here to access the Whitepaper